Oil-Dri of America (ODC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
11 Jan, 2026Executive summary
Achieved record net sales, gross profit, and net income in fiscal 2023, 2024, and Q1 2025, with both operating segments contributing through higher volumes and favorable product mix.
Largest acquisition in company history completed with Ultra Pet, fully integrated and driving additional growth and synergies.
Two-for-one stock split approved for January 2025, following strong shareholder support.
Dividend doubled to $0.08 per share (pre-split), marking 21 consecutive years of increases.
Company recognized as a top workplace and ranked on Forbes' list of America's most successful small-cap companies for the second consecutive year.
Financial highlights
Net sales rose 15% year-over-year to $127.9 million in Q1 2025; gross profit up 32% to $40.8 million; gross margin expanded to 32%.
Net income increased 52% to $16.4 million; diluted EPS climbed to $2.25; EBITDA grew 51% to $26.2 million.
Gross profit per ton and net sales per ton reached $594 in Q1 2025, driven by improved product mix and high-value segments.
Operating cash flow was $10.9 million; capital expenditures totaled $12.8 million; cash and cash equivalents at quarter-end were $12.5 million.
Share price reached approximately $84.49 at the time of the meeting.
Outlook and guidance
Management expects continued positive momentum into fiscal 2025, with full-year benefit from Ultra Pet acquisition and strong positioning in growth markets.
Growth anticipated in fluids purification, agriculture, and animal health segments, with new renewable diesel plants expected to drive future demand.
Advertising expenditures for fiscal 2025 anticipated to be lower than in fiscal 2024.
Continued investment in infrastructure, operational efficiency, and innovation to support long-term growth.
Latest events from Oil-Dri of America
- Q2 net sales hit $117.7M, EBITDA $22M, with resilience despite weather disruptions.ODC
Q2 202612 Mar 2026 - Record net income and Ultra Pet acquisition drive growth, with margin and sales gains.ODC
Q3 20241 Feb 2026 - Record sales, margin expansion, and Ultra Pet integration drive strong growth outlook.ODC
Q4 202419 Jan 2026 - Record FY2025 results with double-digit growth, strong cash flow, and a positive FY2026 outlook.ODC
Q4 20257 Jan 2026 - Record sales, margin expansion, and robust B2B and animal health growth in Q2.ODC
Q2 202526 Dec 2025 - Record results in 2025 and strong Q1 FY2026 earnings drive continued growth and investment.ODC
Q1 2026 & AGM 20259 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve stock split amid strong governance focus.ODC
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and a 2:1 stock split approval.ODC
Proxy Filing1 Dec 2025 - Virtual meeting to elect nine directors, ratify auditor, and highlight ESG and governance priorities.ODC
Proxy Filing1 Dec 2025